Medison Expands APAC Leadership with New Appointment

Medison Pharma has appointed Francis Wan as Vice President and General Manager for the Asia Pacific (APAC) region. This move is part of Medison's strategy to enhance its global commercialization platform. Wan, with over 20 years of experience in biopharmaceutical leadership, has previously held key positions at Biogen and MSD China. His expertise in rare diseases and oncology, particularly in China's healthcare market, will bolster Medison's efforts in the APAC region.

Wan's leadership aims to address the significant unmet needs in the APAC market by expanding access to breakthrough therapies. His appointment underscores Medison's commitment to investing in the region and accelerating growth. The company's founder, Meir Jakobsohn, highlights this as a step towards expanding their reach, emphasizing the importance of timely access to innovative treatments for patients worldwide.